UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $378.14 Million Position in CVS Health Co. (NYSE:CVS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in CVS Health Co. (NYSE:CVS) by 19.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,423,608 shares of the pharmacy operator’s stock after acquiring an additional 1,373,663 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in CVS Health were worth $378,136,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Coppell Advisory Solutions LLC grew its position in CVS Health by 17.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator’s stock valued at $56,000 after buying an additional 189 shares during the period. EagleClaw Capital Managment LLC grew its position in CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock valued at $275,000 after buying an additional 200 shares during the period. Manchester Capital Management LLC lifted its holdings in CVS Health by 4.8% during the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock valued at $200,000 after purchasing an additional 204 shares during the last quarter. Angeles Investment Advisors LLC lifted its holdings in CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator’s stock valued at $256,000 after purchasing an additional 204 shares during the last quarter. Finally, Rogco LP lifted its holdings in CVS Health by 3.2% during the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator’s stock valued at $303,000 after purchasing an additional 210 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. StockNews.com raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $84.00 price objective (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Royal Bank of Canada upped their price objective on shares of CVS Health from $74.00 to $81.00 and gave the company an “outperform” rating in a report on Monday, May 5th. Cowen reaffirmed a “buy” rating on shares of CVS Health in a report on Monday, May 5th. Finally, Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $74.94.

CVS Health Trading Up 1.5%

Shares of CVS Health stock opened at $63.73 on Wednesday. The company’s 50-day moving average price is $66.48 and its 200-day moving average price is $59.32. The company has a market cap of $80.62 billion, a price-to-earnings ratio of 17.41, a PEG ratio of 0.98 and a beta of 0.60. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. CVS Health’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm posted $1.31 earnings per share. On average, equities analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.17%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health’s dividend payout ratio is currently 63.48%.

Insider Activity at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at $556,941.90. This trade represents a 47.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.